Table 2.
Group | Patient number (%) |
||||||
---|---|---|---|---|---|---|---|
Microcytosis (MCV < 80 fL) | Macrocytosis (MCV ≥ 100 fL) | Hb deficiency (Men < 13 g/dL, women < 12 g/dL) | Iron deficiency (<60 μg/dL) | Vitamin B12 deficiency (<200 pg/mL) | Folic acid deficiency (<4 ng/mL) | GPCA positivity | |
BMS patients with hyperhomocysteinemia (n = 170) | 9 (5.3) | 28 (16.5) | 77 (45.3) | 39 (22.9) | 35 (20.6) | 14 (8.2) | 32 (18.8) |
aP-value | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
bP-value | 0.252 | <0.001 | <0.001 | 0.011 | <0.001 | <0.001 | 0.006 |
BMS patients without hyperhomocysteinemia (n = 714) | 59 (8.3) | 18 (2.5) | 98 (13.7) | 104 (14.6) | 7 (1.0) | 6 (0.8) | 77 (10.8) |
aP-value | <0.001 | 0.002 | <0.001 | <0.001 | 0.090 | 0.131 | <0.001 |
Healthy control subjects (n = 442) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 8 (1.8) |
Comparisons of frequencies of parameters between 170 BMS patients with hyperhomocysteinemia or 714 BMS patients without hyperhomocysteinemia and 442 healthy control subjects by chi-square test.
Comparisons of frequencies of parameters between 170 BMS patients with hyperhomocysteinemia and 714 BMS patients without hyperhomocysteinemia by chi-square test.